for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Natus Medical Inc

NTUS.OQ

Latest Trade

18.11USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

16.38

 - 

34.89

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
18.11
Open
--
Volume
--
3M AVG Volume
5.42
Today's High
--
Today's Low
--
52 Week High
34.89
52 Week Low
16.38
Shares Out (MIL)
33.87
Market Cap (MIL)
600.20
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2020 Natus Medical Inc Earnings Release

Latest Developments

More

Natus Medical Inc Says Co Amended The Terms Of Its Five Year Credit Agreement

Natus Medical Q2 Revenue Fell 32.4 Percent To $84.8 Million

Natus Medical Says Withdrew Full Year 2020 Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Natus Medical Inc

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Industry

Medical Equipment & Supplies

Contact Info

6701 Koll Center Pkwy Ste 120

PLEASANTON, CA

94566-8061

United States

+1.925.2236700

http://www.natus.com/

Executive Leadership

Barbara R. Paul

Independent Chairman of the Board

Jonathan A. Kennedy

President, Chief Executive Officer, Director

B. Drew Davies

Chief Financial Officer, Executive Vice President

Lisa Paul

Vice President and Chief People Officer

Austin F. Noll

Executive Vice President and Chief Commercial Officer

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.5K

2018

0.5K

2019

0.5K

2020(E)

0.4K
EPS (USD)

2017

1.450

2018

1.420

2019

1.240

2020(E)

0.110
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.34
Price To Book (MRQ)
1.52
Price To Cash Flow (TTM)
22.31
Total Debt To Equity (MRQ)
21.94
LT Debt To Equity (MRQ)
13.09
Return on Investment (TTM)
-0.48
Return on Equity (TTM)
-0.38

Latest News

Latest News

BRIEF-Natus Medical Says Withdrew Full Year 2020 Guidance

* NATUS MEDICAL - ASIA-PACIFIC REGION HAD MOST SIGNIFICANT NEGATIVE IMPACT ON REVENUE DURING QUARTER, FOLLOWED BY WEAKNESS IN EUROPEAN & LATIN AMERICAN REGIONS

BRIEF-Natus Medical Q4 Non-GAAP Earnings Per Share $0.46

* NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up